Hilltop National Bank lessened its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.7% in the fourth quarter, Holdings Channel.com reports. The firm owned 16,012 shares of the company’s stock after selling 282 shares during the period. Procter & Gamble makes up about 0.8% of Hilltop National Bank’s investment portfolio, making the stock its 28th largest position. Hilltop National Bank’s holdings in Procter & Gamble were worth $2,684,000 at the end of the most recent quarter.
Other institutional investors also recently modified their holdings of the company. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble during the 2nd quarter worth about $28,000. Fairway Wealth LLC acquired a new stake in shares of Procter & Gamble in the second quarter valued at about $29,000. RPg Family Wealth Advisory LLC bought a new stake in Procter & Gamble during the third quarter worth about $33,000. Quest Partners LLC bought a new position in Procter & Gamble in the second quarter valued at approximately $36,000. Finally, Fairfield Financial Advisors LTD acquired a new position in shares of Procter & Gamble during the 2nd quarter worth approximately $44,000. 65.77% of the stock is currently owned by institutional investors.
Insider Activity
In related news, CEO Gary A. Coombe sold 47,847 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 75,439 shares of company stock worth $13,317,460. Corporate insiders own 0.18% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last announced its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analysts’ expectations of $21.99 billion. During the same period last year, the firm posted $1.83 earnings per share. The firm’s quarterly revenue was down .6% compared to the same quarter last year. Research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.
Analysts Set New Price Targets
Several equities analysts recently weighed in on PG shares. JPMorgan Chase & Co. raised their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research note on Thursday, September 19th. Morgan Stanley boosted their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research note on Monday, October 21st. Evercore ISI raised their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research note on Monday, October 21st. Royal Bank of Canada reissued a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research report on Monday, October 21st. Finally, Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Eight investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has a consensus rating of “Moderate Buy” and a consensus price target of $179.75.
View Our Latest Analysis on Procter & Gamble
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Read More
- Five stocks we like better than Procter & Gamble
- How Can Investors Benefit From After-Hours Trading
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Canadian Penny Stocks: Can They Make You Rich?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- How to Calculate Retirement Income: MarketBeat’s Calculator
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.